Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep;10(9):e1218-e1219.
doi: 10.1016/S2214-109X(22)00327-8.

Highlighting the need for investment and innovation in ART retention interventions

Bohdan Nosyk  1 , Lia Humphrey  2
Affiliations
Comment

Highlighting the need for investment and innovation in ART retention interventions

Bohdan Nosyk et al. Lancet Glob Health. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

BN and LH report grants from US National Institute of Health (award number R01-DA041747).

Comment on

References

    1. Bershteyn A, Jamieson L, Kim H-Y, et al. Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models. The Lancet Global Health 2022. - PMC - PubMed
    1. Zang X, Mah C, Quan AML, et al. Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US Cities. J Acquir Immune Defic Syndr 2022; 89(2): 143–50. - PMC - PubMed
    1. Daskalaskis D. The Ending the Epidemic Task Force: New York City Health Department. In: Hygiene NYCDoHaM, editor.
    1. Kanters S, Park JJ, Chan K, et al. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis. Lancet HIV 2017; 4(1): e31–e40. - PubMed
    1. Nosyk B, Lourenço L, Min JE, Shopin D, Lima VD, Montaner JS. Characterizing retention in HAART as a recurrent event process: insights into ‘cascade churn’. AIDS (London, England) 2015; 29(13): 1681. - PMC - PubMed

Substances